0001855763-22-000001.txt : 20220308
0001855763-22-000001.hdr.sgml : 20220308
20220308171841
ACCESSION NUMBER: 0001855763-22-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220308
FILED AS OF DATE: 20220308
DATE AS OF CHANGE: 20220308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baxter Nicholas W
CENTRAL INDEX KEY: 0001312326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39874
FILM NUMBER: 22722789
MAIL ADDRESS:
STREET 1: 220 SPRINGFIELD ROAD
STREET 2: ABERDEEN
CITY: ABERDEENSHIRE, SCOTLAND
STATE: X0
ZIP: AB15 6AU
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexaria Bioscience Corp.
CENTRAL INDEX KEY: 0001348362
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202000871
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0831
BUSINESS ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
BUSINESS PHONE: 250-765-6424
MAIL ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
FORMER COMPANY:
FORMER CONFORMED NAME: LEXARIA CORP.
DATE OF NAME CHANGE: 20080229
FORMER COMPANY:
FORMER CONFORMED NAME: Lexaria Corp.
DATE OF NAME CHANGE: 20051229
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-03-08
0
0001348362
Lexaria Bioscience Corp.
LEXX
0001312326
Baxter Nicholas W
37H KING'S GATE
ABERDEEN
ABERDEEN
X0
AB15 4EL
UNITED KINGDOM
1
0
0
0
common shares
11000
D
Stock Options
5.31
2021-04-26
2026-04-26
Common Shares
1500
1500
D
Stock Options
7.08
2021-06-08
2026-06-08
Common Shares
5000
6500
D
Stock Options
6.23
2021-09-01
2026-09-01
Common Shares
1900
8400
D
Stock Options
3.39
2022-03-08
4
A
0
3400
0
A
2022-03-08
2027-03-08
Common Shares
3400
11800
D
/Nicholas Baxter/
2022-03-08